FDA User Fee Bill Easily Slides Through Senate

Law360, New York (May 24, 2012, 4:12 PM EDT) -- The U.S. Senate on Thursday overwhelmingly approved legislation authorizing the U.S. Food and Drug Administration to collect $2.8 billion in user fees from the drug and device industries, after a strenuous effort to keep controversial and anti-industry amendments, including one targeting pay-for-delay agreements, out of the bill.

The Senate passed its version of the bill in a 96-1 vote. The bill has enjoyed remarkable bipartisan support, flogged by the leaders of the Senate health committee, who worked for more than a year to write a series...
To view the full article, register now.